Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA Medical Dialogues Bureau11 Oct 2019 4:30 AM GMT"The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
Aurobindo Pharma Unit-7 gets 7 USFDA observations Medical Dialogues Bureau8 Oct 2019 9:24 AM GMTThe United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7...
Aurobindo looks for inorganic growth prospects in East Europe Ruby Khatun Khatun27 Nov 2017 5:10 AM GMTMumbai: Hyderabad-based Aurobindo Pharma is looking at inorganic growth opportunities in Eastern Europe and other geographies for deeper market...